Profile

From: WHO, 2015. Myanmar Malaria Profile. Geneva: World Health Organization. Available at: www.who.int

Epidemiological profile of Myanmar

Population by malaria endemicity (000) 2015 %
High transmission (≥ 1 case per 1000 population) 8 520 16
Low transmission (0-1 cases per 1000 population) 23 600 44
Malaria free (0 cases) 21 800 40
Total 53 900  
Parasites and vectors
Major plasmodium species P. falciparum (66%), P. vivax (34%)
Major anopheles species An. dirus, minimus

Intervention policies and strategies

   Intervention   WHO-recommended policy/strategy Yes/no Year adopted
ITN/LLIN

ITNs/LLINs distributed free of charge

ITNs/LLINs distributed to all age groups

Yes

Yes

2000

2000

IRS

IRS is recommended

DDT is used for IRS

Yes

No

1957

-

IPT IPT is used to prevent malaria during pregnancy N/A  
Case management

Patients of all ages should receive diagnostic test

RDTs used at community level

ACT is free for all ages in public sector

Pre-referral treatment with recommended medicines

Oral artemisinin-based monotherapies are not registered

Yes

Yes

Yes

Yes

Yes

1962

2007

2003

2004

--

 

Antimalarial policy Type of medicine Year adopted
First-line treatment of unconfirmed malaria - -
First-line treatment of P.falciparum AL; AM; AS+MQ; DHA-PPQ; PQ 2008
For treatment failure of P.falciparum AS+D; AS+T 2008
Treatment of severe malaria AM; AS; QN 2008
Treatment of P.vivax CQ+PQ(14d) 2008

Therapeutic efficacity tests (therapeutic or parasitological failure, %)

Medicine Year No. of studies Min. Median Max. Follow-up
AL 2007-2015 25 0 1.9 6 28 days
AS+MQ 2011-2013 5 0 0 2.2 42 days
DHA-PPQ 2007-2011 12 0 1.6 5 28 days